Bristol-Myers Squibb Co (NYSE:BMY)


Bristol-Myers Squibb Co is a New York-based pharmaceutical company that develops, manufactures, markets, licenses, and sells nutritional and other pharmaceutical products.

The company reportedly focuses on experimental therapies that address several chronic diseases like AIDS, cancer, heart diseases, diabetes, arthritis, organ transplant rejection, psychiatric disorder, hepatitis, etc.

Perrigo Company, Abbott laboratories, ConvaTec, Pfizer, Mega We Care, Glaxo Smithkline, Johnson & Johnson, etc., are significant leaders in biotechnology, healthcare and the pharmaceutical sector.

The company’s product pipeline includes several medicines under the name ABECMA®, AZACTAM®, BARACLUDE®, ISTODAX®, KENALOG®, etc.

The American firm manufactures affordable medicines using innovative and latest technology.

Bristol-Myers Squibb Co claims to generate most of its revenue from four therapeutic areas:

• Cardiovascular
• Immunology
• Hematology
• Oncology

The pharmaceutical products broadly include small molecule drugs or pills, chemically synthesized drugs produced from biological processes. Small molecule drugs are generally oral medicines, while Biologics are administered using injections.

Bristol-Myers Squibb Co has its facilities in several locations across the globe, including California, Belgium, New Jersey, Japan, India, etc.

The pharma company reportedly generates maximum revenue from its premier products like SPRYCEL®, YERVOY, ELIQUIS®, BARACLUDE® and OPDIVO®.

Bristol-Myers Squibb Co caters to healthcare systems, physicians, clinical groups, patients, etc.

The company operates through various subsidiaries, namely:

• Celgene
• MyoKardia
• Juno Therapeutics
• X-Body Inc
• ZymoGenetics LLC
• RedoxTherapies Inc
• Formation Biologics Inc
• Innate Tumor Immunity Inc
• E.R. Squibb & Sons, LLC

It operates under three geographic business divisions: the United States, Europe and the Rest of the World.

The company's foundation dates back to the 1800s and was officially incorporated as Bristol-Myers Company in 1933, a successor to the New York-based business started in 1887.

In 1989, the company rebranded as Bristol-Myers Squibb Company.

Bristol-Myers Squibb Co sells its product through an extensive network of wholesalers, specialty pharmacies, retailers, hospitals, etc.

Bristol-Myers Squibb Co claims to promote diversity and inclusion and supports female employees by offering flexible working options and on-site child-care facilities.

Contact Information

company address 430 E. 29th Street, 14th Floor, New York, NY 10016

company phone1-800-332-2056


Similar Companies